Halozyme Therapeutics Inc (NASDAQ:HALO)

38.85
BATS BZX Real-Time Price
As of 10:50am ET
 +0.13 / +0.34%
Today’s Change
27.21
Today|||52-Week Range
56.40
-9.04%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues135.1M146.7M316.6M151.9M
 
 
 
 
 
Cost of Goods Sold27.6M30.8M29.0M7.7M
 
 
 
 
 
Depreciation And Amortization1.7M2.4M2.2M2.4M
 
 
 
 
 
 
Operating ExpensesGross Income105.8M113.5M285.5M141.7M
 
 
 
 
 
General Expenses133.3M196.7M204.5M255.3M
 
 
 
 
 
Research And Development93.2M150.8M150.6M194.5M
 
 
 
 
 
Total Operating Expenses162.5M229.9M235.6M265.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-27.5M-83.2M81.0M-113.5M
 
 
 
 
 
Interest Expense On Debt5.2M20.0M22.0M18.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-32.2M-101.9M61.6M-124.0M
 
 
 
 
 
Income Taxes0.00-1.2M-1.4M-43.7M
 
 
 
 
Net Income-32.2M-103.0M63.0M-80.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS126.7M128.0M136.4M143.6M
 
 
 
 
 
Shares To Calculate EPS Diluted126.7M128.0M139.1M143.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.25-$0.81$0.45-$0.56
 
 
 
 
 
EPS Diluted-$0.25-$0.81$0.45-$0.56